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LETTERS TO
THE EDITOR
The time of blood sampling for osteocalcin
determinations
Sir: We have read the interesting article by
Pietschmann et al about the serum osteocalcin
concentrations in patients with rheumatoid
arthritis.' In their work there was no mention
of the time at which blood samples were taken
for osteocalcin determination.
Several studies have shown a circadian
rhythm of serum osteocalcin in normal adults,
with peak values during the night and a nadir
during the morning hours.2 3 Therefore, in
our opinion, if osteocalcin is used as a marker
in clinical investigations of bone metabolism it
is important to mention the time at which
blood was collected for its measurement.
Otherwise, interpretation of results may be
difficult and comparison with values obtained
in other studies impossible.
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Sir: We agree with Drs Nolla and Rozadilla
that in applying serum osteocalcin measure-
ments it is important to take account of the
diurnal variations of serum osteocalcin con-
centrations. In a recent study (Pietschmann
et al, unpublished data) in patients with
postmenopausal osteoporosis we found a
diurnal rhythmicity of serum osteocalcin con-
centrations similar to that described by Gund-
berg et al in normal subjects.' In contrast,
Guillemant and Guillemant did not find
circadian fluctuations of serum osteocalcin
concentrations in patients with primary or
secondary hyperparathyroidism.2 In our study
on serum osteocalcin concentrations in patients
with rheumatoid arthritis3 blood for osteocalcin
measurements was collected from all patients
and controls between 8 00 and 9 00 am.
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Anticardiolipin antibody negative occlusive
vascular retinopathy in systemic lupus
erythematosus
Sir: A strong association has recently been
reported between the presence of anticardio-
lipin antibody and occlusive ocular vascular
disease in patients with systemic lupus ery-
thematosus (SLE). ' 2 We now wish to report a
patient with SLE who developed bilateral
central retinal artery occlusion and in whom
anticardiolipin antibody was not detected
despite several other features suggesting the
presence of antiphospholipid antibodies.
The patient, a 30 year old nursing sister,
was diagnosed as having SLE3 in 1982. She
had a history of two spontaneous abortions. In
January 1986 she had a 'flare' of SLE, which
resolved after one month's treatment with
steroids (prednisone 50 mg daily) and chloro-
quine (200 mg daily). The lupus remained
quiescent, both clinically and serologically, for
the ensuing 10 months during treatment with
prednisone (10 mg alternate days) and chloro-
quine (200 mg daily).
In November 1986 she developed sudden
complete loss of vision in the left eye. Two
days later a similar visual deficit developed in
the right eye. She was admitted to Kalafong
Hospital 20 hours later and ophthalmoscopy
disclosed a pale fundus with a bright red fovea
bilaterally. The arteries were attenuated and
apparently bloodless. Foci of retinal ischaemia
('soft exudates') were evident. An ophthal-
mologist affirmed the appearances were patho-
gnomonic of central retinal artery occlusion.
No other clinical evidence of active lupus or
other predisposing factors for central retinal
artery occlusion were present. Relevant in-
vestigations showed thrombocytopenia of
34x 109/l, a prolonged activated partial
thromboplastin time (APTT) of 50-76 s
(control <40 s), and positive antinuclear
antibody titre of 1/40. The erythrocyte
sedimentation rate, anti-DNA antibody,
serum complement, and gammaglobulin
concentrations, white cell count, haemo-
globin, urine analysis, and echocardiogram
were all normal. She declined further hospital
treatment.
In February 1987, six days after being
admitted to hospital for social reasons, she
developed a mild transient ischaemic attack.
Again there were no other clinical or labora-
tory features of active lupus. The APTT was
now 37 s, the rapid plasma reagin test was
negative, and an enzyme linked immuno-
sorbent assay (ELISA) (The Rayne Institute,
St Thomas's Hospital, London) showed
absence of anticardiolipin antibody. She again
declined further hospital treatment.
Three months later she was readmitted after
having developed loss of consciousness
abruptly five hours earlier. She was comatose
with dilated pupils, which reacted sluggishly
to light. She had a right hemiparesis. A
computed tomographic brain scan was per-
formed within a few hours after admission.
This showed multiple areas of low attenuation
in both hemispheres consistent with infarc-
tions. The lateral ventricles were mildly
dilated and several cortical sulci appeared
unduly prominent (figure). The platelet count
was 52x 109/1 and APTT 76 s. Anticardiolipin
antibody was once more not detected and
the rapid plasma reagin test was again
negative. Antibodies to Ro and La were
negative but antibodies to RNP and Sm were
positive. She was initially anticoagulated with
heparin and subsequently with warfarin. High
doses of cyclophosphamide, prednisone, and
aspirin were also prescribed, but her clinical
state remained unchanged and she died six
weeks later. Permission for necropsy was not
granted.
Recurrent fetal loss, occlusive stroke,
Computed tomographic brain scan showing
multiple infarcts and cerebral atrophy.
thrombocytopenia, and a prolonged APTT-
all features that existed in our patient-have
been associated with the presence of anti-
phospholipid antibodies.4 The failure in this
case to detect anticardiolipin antibody is
therefore noteworthy. In our recent study of
SLE in black South Africans clinical features
were found to be little different from those
described in series from other parts of the
world.5 Four of the 30 patients had a history
of cerebrovascular accidents. Of these, three
were tested for the presence of anticardiolipin
antibody and the levels were found to be
normal in each (Dessein PH, Gledhill RF,
Asherson RA, unpublished). Moreover, of the
12 other patients tested, only one was found to
have a raised anticardiolipin antibody level
and this patient had no clinical features of the
antiphospholipid syndrome.4 It is our im-
pression that the incidence of antiphospholipid
antibodies may be significantly less in Africans
with SLE. Our patient is another example of
anticardiolipin antibody negativity in the
presence of probable lupus anticoagulant
positivity, a finding observed by other investi-
gators.6
Although occlusion of both central retinal
arteries in rapid succession, such as appeared
in this patient, seems an exceptional circum-
stance, the observation by Stafford-Brady et
a12 that retinopathy in SLE may be a marker
of poor prognosis for survival is shown only
too well by our case.
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